PDX Portal

PDX INSIGHTS

PIONEERING CANCER RESEARCH

Breast Collection

Collection Summaries:

Collection Details:

Search All Columns:

			Patient Biomarkers at Diagnosis			PDX Biomarkers
Model IDFilter by Model ID	Patient IDFilter by Patient ID	Pathology Diagnosis	ERFilter by ER	PRFilter by PR	HER2Filter by HER2	ERFilter by ER	PRFilter by PR	HER2Filter by HER2	Germline BRCA1 StatusFilter by Germline BRCA1 Status	Germline BRCA2 StatusFilter by Germline BRCA2 Status	Path Stage	Grade	Clinical Event Pt	Age at Diagnosis	Race	Treatment NaiveFilter by Treatment Naive	Patient TreatmentFilter by Patient Treatment
BCM-0002	24452	Infiltrating ductal carcinoma	Not Reported	Not Reported	Not Reported	Negative	Negative	Negative	Wild type	Wild type			Distant Metastasis	43.62	Black or African American	No	Anastrozole,Capecitabine,Carboplatin,Docetaxel,Doxorubicin,Gemcitabine,Letrozole,Paclitaxel,Tamoxifen
BCM-0046	2219	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Wild type	Wild type	IIB	G3 (Poorly Differentiated)	Primary	53.47	Hispanic or Latino	No	Cyclophosphamide,Docetaxel,Epirubicin
BCM-0113	4661	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Wild type	Wild type	Unknown	G3 (Poorly Differentiated)	Distant Metastasis	63.38	Hispanic or Latino	No	Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Ixabepilone,Paclitaxel
BCM-15034	33355	Infiltrating ductal carcinoma	Positive	Negative	Negative	Positive	Positive	Unknown	Wild type	Wild type	Unknown	G3 (Poorly Differentiated)	Distant Metastasis	62.88	White	No	Anastrozole,Capecitabine,Docetaxel,Eribulin,Everolimus,Exemestane,Letrozole,Paclitaxel,Palbociclib,Pertuzumab,Trastuzumab
BCM-15100	24590	Infiltrating ductal carcinoma	Positive	Positive	Negative	Positive	Positive	Negative	Not Reported	Not Reported			Distant Metastasis	38.00	White		Capecitabine,Carboplatin,Cyclophosphamide,Docetaxel,Doxorubicin,Eribulin,Fulvestrant,Letrozole,Leuprolide,Other,Paclitaxel,Palbociclib,Tamoxifen
BCM-15115	39639	Infiltrating ductal carcinoma	Negative	Negative	Negative	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	IIIA	G3 (Poorly Differentiated)	Primary	63.76	Hispanic or Latino	No	Anastrazole,Paclitaxel
BCM-2147	24455+	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IIIA	G3 (Poorly Differentiated)	Primary	32.97	Black or African American	Yes	Bevacizumab,Capecitabine,Cyclophosphamide,Docetaxel,Doxorubicin,Other,Paclitaxel
BCM-2277	24455+	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IIIA	G3 (Poorly Differentiated)	Primary	32.97	Black or African American	No	Bevacizumab,Capecitabine,Cyclophosphamide,Docetaxel,Doxorubicin,Other,Paclitaxel
BCM-2665	24457	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IIA	G3 (Poorly Differentiated)	Distant Metastasis	50.26	Hispanic or Latino	No	Capecitabine,Cyclophosphamide,Docetaxel,Doxorubicin
BCM-3204	24460	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	Unknown		Primary	42.25	White	Yes	Cyclophosphamide,Docetaxel,Doxorubicin
BCM-3561	24464	Lobular carcinoma in situ	Positive	Positive	Negative	Negative	Negative	Negative	Not Reported	Not Reported		G2 (Moderately Differentiated)	Distant Metastasis	56.16	White	No	Anastrozole,Capecitabine,Cyclophosphamide,Doxorubicin,Other,Paclitaxel
BCM-3611	24465	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported		G2 (Moderately Differentiated)	Primary	58.41	Black or African American	Unknown	Capecitabine,Cyclophosphamide,Docetaxel,Doxorubicin,Experimental Drugs
BCM-3613	24965	Infiltrating ductal carcinoma	Negative	Negative	Positive	Negative	Negative	Positive	Not Reported	Not Reported	Unknown		Distant Metastasis	37.78	Hispanic or Latino	No	Capecitabine,Cyclophosphamide,Docetaxel,Doxorubicin,Exemestane,Gemcitabine,Lapatinib,Letrozole,Paclitaxel,Tamoxifen,Trastuzumab,Vinorelbine
BCM-3807	24466+	Infiltrating ductal carcinoma	Positive	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IIIA	G3 (Poorly Differentiated)	Primary	37.14	Hispanic or Latino		Capecitabine,Cyclophosphamide,Docetaxel,Doxorubicin,Tamoxifen
BCM-3887	56058	Infiltrating ductal carcinoma	Not Reported	Not Reported	Not Reported	Negative	Negative	Negative	Mutant	Not Reported			Recurrence	27.16	Black or African American	No	Capecitabine,Spine

* indicates the model is private.
+ indicates the patient has multiple models.

SITE LINKS

Collections
Omics Tools
Publications
Our Team
Contact Us

COLLECTIONS

Bladder Breast Leukemia Liver Pancreas Sarcoma

CONTACT

PDX Development Unit
BCM PDX Core
PDX Pediatric Liver Program
Baylor College of Medicine

SUPPORTED BY

Cancer Prevention and Research
Institute of Texas (RP220646)

Dan L Duncan Cancer Center (P30 Cancer Center Support Grant NCI-CA125123)
Advanced Technology Core

© 2024 Biomedical Informatics Group, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine